Product Manager at PT Bayer Indonesia

Responsible for managing and developing product strategies for the antihypertensive portfolio (Nifedipine OROS) and contraceptive device products (IUD & IUS). Led market strategies to strengthen product positioning within the Calcium Channel Blocker market and increase acceptance among Internists, Cardiologists, Neurologists, and Nephrologists. Led initiatives to expand product adoption within the national healthcare system (JKN), positioning antihypertensive therapy as a first-line treatment for hypertension. Designed engagement strategies to increase midwife adoption of IUD products as a preferred long-term contraceptive option. Developed educational and awareness initiatives targeting OBGYNs, hospitals, and patients to increase acceptance of IUS products as hormonal therapy and long-term contraception. Implemented hospital-based education programs and patient-awareness campaigns to improve disease awareness and encourage early treatment. Key milestones: Improved acceptance of antihy

Digital Activation Manager at Bayer

Led digital activation initiatives across Bayer’s focus brands by collaborating with product teams to develop integrated digital engagement strategies targeting both healthcare professionals (HCPs) and patients. Consolidated digital activation strategies across multiple pharmaceutical brands, aligning communication and engagement initiatives for both HCP and patient audiences. Developed and launched a telehealth-based contraceptive access program enabling patients to access contraceptive information, online consultations, and product purchasing through a single digital platform. Collaborated with healthcare professional communities and digital media partners to strengthen engagement and awareness for contraceptive solutions. Contributed to the 2022 brand planning process by developing strategic imperatives for digital activation across focus brands. Key Achievement: Launched Bayer’s telehealth initiative for contraceptive access, increasing prescription conversion through the telec

Product Executive at Bayer

Selected for a short-term assignment supporting product management initiatives across multiple specialty medicine portfolios, including anti-VEGF therapy, hepatocellular carcinoma (HCC) treatment, and testosterone therapy. Contributed to the 2021 brand plan for the anti-VEGF portfolio, supporting strategic direction and execution of brand initiatives to maintain market leadership. Supported market expansion initiatives for testosterone therapy by strengthening its positioning as a first-line treatment in andrology and increasing awareness among endocrinology specialists. Managed engagement with healthcare professionals across multiple specialties including retina specialists, endocrinologists, andrologists, internists, and hepatologists. Implemented digital and educational engagement initiatives including webinars, CME programs, and approved email campaigns to strengthen HCP relationships and product awareness. Key Achievement: Established a new strategic relationship with a leading en

Marketing Activation Officer at Bayer

Supported marketing activation initiatives for the Women’s Health portfolio (contraceptive products) by leading brand activation activities targeting both patients and healthcare professionals. Led brand activation initiatives targeting the layman audience by developing digital assets and educational content to improve awareness and understanding of contraceptive options. Supported scientific engagement activities with healthcare professionals including OBGYNs and midwives to strengthen awareness and adoption of Bayer’s Women’s Health portfolio. Collaborated with internal teams to align marketing communication and educational initiatives across digital and professional channels. Key Achievement: Successfully launched “BicaraKontrasepsi,” a digital information platform designed to educate patients about contraceptive options and serve as a reference resource prior to consulting healthcare professionals.